BUZZ-India's Senores Pharma rises on acquisition of rights to sell Roflumilast

Shares of Senores Pharmaceuticals Ltd SENO.NS rise as much as 5.8% to 565 rupees

Co via its unit acquires USFDA-approved abbreviated new drug application (ANDA) for Roflumilast 250 mcg, 500 mcg tablets used to treat flare-ups in people with severe chronic obstructive pulmonary disease

Adds, acquisition will be funded through initial public offer proceeds

Stock on track to gain for 3rd straight day

SENO last up 4%, cutting YTD losses to 6.1%